Zobrazeno 1 - 10
of 26
pro vyhledávání: '"G. J. van Steenbrugge"'
Autor:
Emma M, Baas, Michelle, Romijn, Sylvia M, van der Pal, Elianne J L E, Vrijlandt, Joost, Rotteveel, Martijn J J, Finken, G J, van Steenbrugge
Publikováno v:
Endocrine. 73(1)
Autor:
M J J, Finken, M G, Keijzer-Veen, F W, Dekker, M, Frölich, F J, Walther, J A, Romijn, B J, van der Heijden, J M, Wit, G J, van Steenbrugge
Publikováno v:
Archives of Disease in Childhood-Fetal and Neonatal Edition, 93(6), F442-F447. BMJ Publishing Group
Finken, M J J, Keijzer-Veen, M G, Dekker, F W, Frolich, M, Walther, F J, Romijn, J A, van der Heijden, B J & Wit, J M 2008, ' Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation ', Archives of Disease in Childhood-Fetal and Neonatal Edition, vol. 93, no. 6, pp. F442-F447 . https://doi.org/10.1136/adc.2007.128470
Archives of disease in childhood. Fetal and neonatal edition, 93(6), F442-F447. BMJ Publishing Group
Archives of Disease in Childhood. Fetal and Neonatal Edition, 93, 442-447. BMJ Publishing Group
Finken, M J J, Keijzer-Veen, M G, Dekker, F W, Frolich, M, Walther, F J, Romijn, J A, van der Heijden, B J & Wit, J M 2008, ' Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation ', Archives of Disease in Childhood-Fetal and Neonatal Edition, vol. 93, no. 6, pp. F442-F447 . https://doi.org/10.1136/adc.2007.128470
Archives of disease in childhood. Fetal and neonatal edition, 93(6), F442-F447. BMJ Publishing Group
Archives of Disease in Childhood. Fetal and Neonatal Edition, 93, 442-447. BMJ Publishing Group
BACKGROUND: A single course of maternal glucocorticoid treatment is effective in reducing neonatal mortality after preterm birth. However, in animals, maternal glucocorticoid treatment is associated with lifelong hyperglycaemia and hypertension, and
Autor:
Margreet J, Teune, Aleid G, van Wassenaer, Paula, van Dommelen, Ben Willem J, Mol, Brent C, Opmeer, G J, van Steenbrugge
Publikováno v:
American Journal of Obstetrics and Gynecology, 204(5). MOSBY-ELSEVIER
American journal of obstetrics and gynecology, 204(5), 396.e1-396.e14. Mosby Inc.
American journal of obstetrics and gynecology, 204(5), 396.e1-396.e14. Mosby Inc.
Objective: Many obstetric interventions are performed to improve long-term neonatal outcome. However, long-term neonatal outcome is usually not a primary outcome because it is time-consuming and expensive. The aim of this project was to identify diff
Autor:
Elysée T M, Hille, Caroline, Dorrepaal, Rom, Perenboom, Jack Bennebroek, Gravenhorst, Ronald, Brand, S Pauline, Verloove-Vanhorick, G J, van Steenbrugge
Publikováno v:
Journal of pediatrics, 152(6). Mosby Inc.
Journal of Pediatrics, 6, 152
Journal of Pediatrics, 6, 152
Objective: To assess social lifestyle, risk-taking behavior, and psychopathology in young adults born very preterm or with a very low birthweight. Study design: This study was part of the 19-year follow-up in a large ongoing collaborative study in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e824362fa90b8c9557a3af6267f5bf6
http://resolver.tudelft.nl/uuid:ab9e403a-3a90-4fb3-b884-b0c5699675c2
http://resolver.tudelft.nl/uuid:ab9e403a-3a90-4fb3-b884-b0c5699675c2
Publikováno v:
Anticancer research. 21(5)
Renal Cell Carcinomas (RCCs) exhibit strong resistance to the most chemotherapeutic treatments probably due to the expression of various multidrug resistance (MDR) genes. Overexpression of P-glycoprotein (Pgp) is established as one such factor, but o
Autor:
M A, Ghanem, T H, Van Der Kwast, J C, Den Hollander, M K, Sudaryo, R B, Mathoera, M M, Van den Heuvel, M A, Noordzij, R J, Nijman, G J, van Steenbrugge
Publikováno v:
Cancer. 92(12)
Wilms tumor is one of the most common solid tumors in children. A transforming growth factor-alpha (TGF-alpha)/epidermal growth factor receptor (EGF-R) autocrine loop plays an important role in tumor growth. Abnormal expression of TGF-alpha, EGF-R an
Autor:
J, Jongsma, M H, Oomen, M A, Noordzij, J C, Romijn, T H, van Der Kwast, F H, Schröder, G J, van Steenbrugge
Publikováno v:
The Prostate. 42(1)
Androgen-independent growth leads to progressive prostate cancer after androgen-ablation therapy. This may be caused by altered specificity of the androgen receptor (AR), by ligand-independent stimulation of the AR, or by paracrine growth modulation
Autor:
G T, Chang, N, Tapsi, M, Steenbeek, L J, Blok, W M, van Weerden, D C, van Alewijk, B H, Eussen, G J, van Steenbrugge, A O, Brinkmann
Publikováno v:
International journal of cancer. 83(4)
Using differential-display RT-PCR analysis between androgen-dependent LNCaP-FGC and androgen-independent LNCaP-LNO human prostate-cancer cells, we have identified a gene not previously described as being expressed in prostate. The gene is more highly
Publikováno v:
International journal of cancer. 84(5)
Decreased expression of CD44 is an independent prognostic marker for surgically treated prostate cancer. To investigate immunohistochemically defined CD44 expression in primary and metastatic prostate cancer, 2 groups of patients undergoing radical p
Publikováno v:
International journal of cancer. 80(3)
Down-regulation of the cell-surface adhesion molecule CD44 has been suggested to play an important role in tumor progression and metastasis of prostate cancer. CD44 is encoded by a gene that contains a CpG-rich region (CpG island) in its 5' regulator